Aug 2026· International Health Sciences Review· Vol 2· 0 citations
TL;DR
Gastrectomy remains the reference treat ment when nodal risk is clinically relevant or endoscopic resection is noncurative, and the choice should therefore be based on predicted lymph-node risk, probability of complete en bloc resection, physiological reserve, surveillance feasibility, and patient preferences rather than on chronological age or tumor depth alone.
Abstract
Early gastric cancer presents a treatment dilemma because oncologic cure may be achieved either by organ-preserving endoscopic resection or by gastrectomy with lymph-node dissection. This structured narrative, critical, and descriptive review examined clinical guidelines, prospective trials, comparative cohorts, systematic reviews, and meta-analyses identified in PubMed/MEDLINE, the Cochrane Library, and professional-society sources through August 2026. Endoscopic submucosal dissection provides excellent disease-specific survival when lesions satisfy validated criteria associated with a negligible risk of lymph-node metastasis and when histopathological assessment confirms curative resection. Comparative observational studies and meta-analyses generally show overall and disease-specific survival similar to gastrectomy in appropriately selected patients, with shorter hospitalization, fewer long-term treatment-related complications, better gastric-cancer-specific quality of life, and lower initial costs. Endoscopic treatment nevertheless produces more local, synchronous, and metachronous gastric neoplasms because the stomach remains at risk, resulting in lower recurrence-free survival and a lifelong requirement for endoscopic surveillance. Gastrectomy remains the reference treat ment when nodal risk is clinically relevant or endoscopic resection is noncurative. The choice should therefore be based on predicted lymph-node risk, probability of complete en bloc resection, physiological reserve, surveillance feasibility, and patient preferences rather than on chronological age or tumor depth alone.
Esophageal Cancer: Surgical Treatment of Esophageal Cancer
Salvage esophagectomy represents an alternative strategy to standard multimodal treatment of resectable esophageal cancer. However, its definition is heterogeneous and further investigation is required to better characterize outcomes and inform pat...
Jin-soo Park, F. Allison, Jonathan Allen et al.· Diseases of the esophagus· 0 citations
Following the endoscopic resection of pT1 colorectal cancer, additional surgery with lymph node dissection is recommended for patients with pathological features associated with an increased risk of lymph node metastasis (LNM) [1]. This strategy is supported by substantial evidence showing that established pathological...
Gastric cancer remains a major global cancer burden and continues to contribute to cancer-related morbidity and mortality in the U.S. It predominantly affects older adults, with a median age at diagnosis of approximately 68 years and nearly 60% of cases occurring in individuals aged 65 years or older. Endoscopic subm...
Yun-Tong Wang, Sangwon Lee, Ji-Yu Sun et al.· Scientific Reports· 0 citations
Introduction: The optimal extent of lymphadenectomy for gastric cancer remains controversial, particularly in Western practice, where concerns regarding postoperative morbidity have historically limited the wide-spread adoption of D2 dissection. This study aimed to compare the perioperative safety and long-term on-colo...
Huseyin Kocaaslan, Cengiz Ceylan, M. Güzel et al.· Laparoscopic Endoscopic Surg...· 0 citations
Abstract Gastric cancer remains a leading cause of cancer‐related mortality worldwide, with nearly 1 million new cases diagnosed annually. Despite innovations in diagnosis, most patients still present at advanced stages, contributing to a poor prognosis. For early gastric cancer, endoscopic resection or minimally invas...